FTSE Flat as Wall Street Gains Fail to Inspire

FTSE mostly flat as housebuilders outperform; ImmuPharma slides, US gains fail to lift London sentiment.

Bert O Bert O

London equities were mostly subdued on Monday, leaving the FTSE 100 slightly lower while the mid-cap and AIM markets edged higher.

The FTSE 100 closed down 0.1% at 9,534.91, the FTSE 250 added 0.2% to 21,411.58, and the AIM All-Share rose 0.2% to 737.16.

Housebuilders took centre stage after Goldman Sachs published its first sector coverage, painting a mixed but generally positive picture. Persimmon led the FTSE 100, climbing 2.1% after the broker started coverage with a ‘buy’ rating and a 1,446p price target.

Vistry jumped 4.5% following a ‘buy’ rating, with Goldman highlighting its strong positioning in the affordable housing segment and potential to benefit from increased government grant funding.

Berkeley ended down 0.5% on a ‘sell’ rating, while Taylor Wimpey and Bellway were modestly lower following neutral ratings.

Analysts noted that earnings growth in the sector is expected to accelerate over the next three years, and any uncertainties ahead of the UK budget could provide a “clearing event” for the market. Chancellor Rachel Reeves is reportedly set to fund 350 additional planners to support the government’s target of 1.5 million new homes.

Advertisement

On AIM, DSW Capital surged 10% after reporting a more than doubling of pretax profit to £237,000 for the six months to September 30. Revenue jumped to £2.8 million from £1.1 million, following the acquisition of DR Solicitors. The group also increased its interim dividend by 20% to 1.2p per share.

ImmuPharma plunged 31% after confirming it had extended the timeline for a partnership deal for its lead asset P140 into 2026, from the end of 2025. Discussions with potential partners, including top global pharmaceutical companies, are ongoing.

In the US, equities were stronger. The Dow rose 0.3%, the S&P 500 added 1.1%, and the Nasdaq gained 1.9%.

A Dallas Fed survey showed Texas manufacturing surged in November, though broader business sentiment remained weak and employment flat. The production index jumped to 20.5 from 5.5, signalling a strong pickup in output, while the general business activity index deteriorated to -10.4, highlighting ongoing caution among executives.